Document Detail


Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target.
MedLine Citation:
PMID:  20498218     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The proinflammatory and anti-inflammatory role of the sympathetic nervous system in early and late inflammation is an unresolved paradox. A drastic loss of sympathetic nerve fibres in the synovial tissue of patients with rheumatoid arthritis (RA) has previously been demonstrated. The presence of tyrosine hydroxylase (TH)-positive cells in RA and osteoarthritis (OA) has been determined, but the role of these cells in inflammation is still unclear. OBJECTIVE: To characterise TH-positive cells in inflamed RA and OA synovial tissue and to study their role in inflammation. METHODS: Synovial samples were obtained from 32 patients with OA and 19 patients with RA and from 10 control patients. Synovial tissue samples were used for immunofluorescence staining. Synovial cells were isolated by tissue digestion and immediately used for cell culture. For in vivo experiments, collagen type-II arthritis in DBA/1J mice was induced. RESULTS: TH+ cells were present only in inflamed tissue and not in controls. Catecholamine-storing vesicles and vesicular monoamine transporter 2 (VMAT2) were identified in the synovial tissue. Experimental increase of cytoplasmic catecholamines by VMAT2 blockade strongly reduced tumour necrosis factor (TNF) independently of canonical extracellular β-adrenergic signalling. In addition, VMAT2 blockade increased cyclic AMP (cAMP) and cAMP responsive element binding protein, responsible for TNF inhibition. In vivo, appearance of VMAT2 positive cells was confirmed. VMAT2 blockade ameliorated inflammation also in vivo. CONCLUSIONS: This study demonstrates that local catecholamine-producing cells start to replace sympathetic nerve fibres around the onset of disease, and modulation of locally produced catecholamines has strong anti-inflammatory effects in vivo and in vitro.
Authors:
Silvia Capellino; Marco Cosentino; Christine Wolff; Martin Schmidt; Joachim Grifka; Rainer H Straub
Related Documents :
9182918 - Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine syn...
19444918 - Prion protein ablation increases cellular aggregation and embolization contributing to ...
16507758 - N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosp...
9864418 - Detection of uv-induced k-ras codon 12 mutation by pcr and differential dot-blot hybrid...
7128208 - Chromosomal aberrations in chinese hamster cells exposed in vitro to tritium-labelled t...
18339858 - Oxidative stress is inherent in prostate cancer cells and is required for aggressive ph...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-05-24
Journal Detail:
Title:  Annals of the rheumatic diseases     Volume:  69     ISSN:  1468-2060     ISO Abbreviation:  Ann. Rheum. Dis.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-22     Completed Date:  2010-10-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372355     Medline TA:  Ann Rheum Dis     Country:  England    
Other Details:
Languages:  eng     Pagination:  1853-60     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine I, Laboratory of Experimental Rheumatology and Neuroendocrino-Immunology, University Hospital, 93042 Regensburg, Germany. silvia.capellino@klinik.uni-regensburg.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic Fibers / metabolism,  pathology
Adult
Animals
Anti-Inflammatory Agents, Non-Steroidal / pharmacology,  therapeutic use
Arthritis, Experimental / drug therapy,  metabolism,  pathology
Arthritis, Rheumatoid / metabolism*,  pathology
Catecholamines / biosynthesis*
Cells, Cultured
Cytoplasm / metabolism
Drug Evaluation, Preclinical / methods
Humans
Mice
Mice, Inbred DBA
Middle Aged
Neurotransmitter Agents / metabolism*
Osteoarthritis, Knee / metabolism*,  pathology
Reserpine / pharmacology,  therapeutic use
Synovial Membrane / innervation,  metabolism*,  pathology
Tumor Necrosis Factor-alpha / antagonists & inhibitors,  metabolism
Tyrosine 3-Monooxygenase / metabolism
U937 Cells
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Catecholamines; 0/Neurotransmitter Agents; 0/Tumor Necrosis Factor-alpha; 50-55-5/Reserpine; EC 1.14.16.2/Tyrosine 3-Monooxygenase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Increased prevalence of diastolic dysfunction in rheumatoid arthritis.
Next Document:  Thyrotropin Serum Values and 3-Year Mortality in Nonagenarians.